Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 6Recruiting 4Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1CNS 1Breast 1

Conditions

Colonic Neoplasms 2Inflammatory Bowel Diseases 1Diverticulitis 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 69Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Tea × Gastrointestinal × Clear all
NCT01239095 2023-02-22

Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection

Northwell Health

Phase 1 Terminated
23 enrolled
Gastrointestinal

Colonic Neoplasms

NCT01062919 2015-08-04

Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Terminated
10 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡